yingweiwo

iGluR

iGluR

The neurotransmitter glutamate activates the iGluR (ionotropic glutamate receptor), an ion channel that is ligand-gated. The central ion channel pore is formed by four large subunits of the integral membrane protein iGluR. All known glutamate receptor subunits, including the AMPA, kainate, NMDA, and  receptors, share a similar amino acid sequence.

The primary charge carriers during basal transmission are AMPA receptors, which allow an influx of sodium ions to depolarize the postsynaptic membrane. Magnesium ions block NMDA receptors, which only allow ion flux after a previous depolarization. They can now serve as coincidence detectors for synaptic plasticity because of this. NMDA receptors allow calcium to enter the body, which permanently changes how strongly synaptic transmission is carried out.
 

iGluR related products

Structure Cat No. Product Name CAS No. Product Description
CGP-78608 V87171 CGP-78608 206648-13-7 CGP 78608 is a highly potent and selective antagonist of the glycine binding site of NMDA receptors with an IC50 of 6 nM.
CIQ V18373 CIQ 486427-17-2 CIQ is a novel, potent and GluN2C/GluN2D subunit-selective NMDA receptor potentiator, which reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.
cis-ACPD V70468 cis-ACPD 477331-06-9 cis-ACPD is a potent NMDA receptor agonist/activator with IC50 of 3.3 μM.
Cl-HIBO V70467 Cl-HIBO 909400-43-7 Cl-HIBO is a highly isoform-selective GluR1/2 agonist (EC50 of 4.7 and 1.7 μM, respectively).
CNQX Disodium V18479 CNQX Disodium 479347-85-8 CNQX Disodium (FG-9065), the disodium salt form of CNQX, is a potent AMPA/kainate antagonist with higherwater-solubility than the free acid formCNQX(Cat.
Co 101244 V93661 Co 101244 193359-26-1 Co-101244 (PD 174494) is an NMDA receptor blocker that specifically targets the NR2B subunit.
Conantokin G TFA V78852 Conantokin G TFA Conantokin G TFA is a 17 amino acid (AA) peptide that is a specific and competitive N-methyl-D-aspartate (NMDA) receptor antagonist.
Conantokin R (Con-R) V70477 Conantokin R (Con-R) 202925-60-8 Conantokin R (Con-R) is an NMDA receptor peptide antagonist (inhibitor) with IC50 of 93 nM.
Conantokin-T V70484 Conantokin-T 127476-26-0 Conantokin-T is an N-methyl-D-aspartate (NMDA) antagonist peptide containing γ-carboxyglutamate with IC50 of 2 μM.
CP-465022 hydrochloride V70449 CP-465022 hydrochloride 1785666-59-2 CP-465022 HCl is a specific, noncompetitive AMPA receptor antagonist (inhibitor) with anticonvulsant (antiepileptic/antiseizure) activity.
Crocetin meglumine (Transcrocetin meglumine; trans-Crocetin meglumine) V77135 Crocetin meglumine (Transcrocetin meglumine; trans-Crocetin meglumine) Crocetin (Transcrocetin) meglumine, found in saffron (Crocus sativus L.), is a high-affinity NMDA receptor antagonist.
CX546 V18913 CX546 215923-54-9 CX546 is an AMPA receptor potentiator.
Cycloleucine (Cycloleucine) V70388 Cycloleucine (Cycloleucine) 52-52-8 Cycloleucine is a specific inhibitor of S-adenosylmethionine-mediated methylation.
D-AP4 (D-APB; D-2-Amino-4-phosphonobutyric acid) V70488 D-AP4 (D-APB; D-2-Amino-4-phosphonobutyric acid) 78739-01-2 D-AP4 (D-APB; D-2-Amino-4-phosphonobutyric acid) is a phosphate analog of glutamate and an NMDA broad-spectrum excitatory amino acid (AA) receptor antagonist.
D-NMAPPD ((1R,2R)-B13) V70434 D-NMAPPD ((1R,2R)-B13) 35922-06-6 D-NMAPPD ((1R,2R)-B13) is an acid ceramidase inhibitor.
Decanoic acid-d19 (decanoic acid d19) V70448 Decanoic acid-d19 (decanoic acid d19) 88170-22-3 Decanoic acid-d199 is the deuterated form of Decanoic acid.
Decanoic acid-d2 (decanoic acid d2) V70490 Decanoic acid-d2 (decanoic acid d2) 62716-49-8 Decanoic acid-d2 is the deuterated form of Decanoic acid.
Decanoic acid-d3 (decanoic acid d3) V70422 Decanoic acid-d3 (decanoic acid d3) 102611-15-4 Decanoic acid-d3 is the deuterated form of Decanoic acid.
Delucemine V87170 Delucemine 186495-49-8 Delucemine is a selective serotonin reuptake inhibitor (SSRI) and NMDAR antagonist.
DL-AP5 lithium V102444 DL-AP5 lithium 125229-62-1 DL-AP5 (2-APV) lithium is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist.
Contact Us